Literature DB >> 2645051

Induction of tumoricidal macrophages from bone marrow cells of normal mice or mice bearing a colony-stimulating-factor-producing tumor.

S Hosoe1, T Ogura, S Hayashi, K Komuta, T Ikeda, T Shirasaka, I Kawase, T Masuno, S Kishimoto.   

Abstract

Nonadherent cells of the bone marrow of C3H/HeN mice were incubated for 3 days with the culture supernatant of an L-929 cell line containing macrophage-colony-stimulating factor. Approximately, 70% of the cells became phagocytic, adherent to plastic dishes and positive for nonspecific esterase staining. The adherent cells exhibited a weak tumoricidal activity against syngeneic mammary carcinoma cells, and the cytotoxicity was strongly augmented by the addition of bacterial lipopolysaccharide to the cytotoxicity assay. The cytotoxicity induced by lipopolysaccharide was also shown to be mediated by Thy1.2- and asialo-GM1+ cells, and was abrogated by the addition of carrageenan. Macrophage-colony-stimulating-factor-producing (D66) and nonproducing (A23) variants were separated from the MM48 tumor line in in vitro culture following limiting dilution. There was no difference between these two variants in either the in vitro growth rate or the susceptibility to macrophage-mediated cytotoxicity. C3H/HeN mice inoculated i.p. with D66 survived longer than did those inoculated i.p. with A23. C3H/HeN mice bearing D66 or A23 as an ascitic form were given i.p. injections of Nocardia rubra cell wall skeleton (N-CWS). N-CWS significantly prolonged the survival period of mice bearing D66, whereas it exhibited no apparent antitumor effect on mice bearing A23. The increase in the cell number of D66 in the peritoneal cavity was significantly retarded, compared with that of A23. In contrast, the number of peritoneal macrophages increased more in D66-bearing mice than in A23-bearing mice. The increase in the peritoneal macrophage number was further augmented by an i.p. injection of N-CWS. Peritoneal macrophages of D66-bearing mice exhibited apparent tumoricidal activity against MM48 tumor cells in the presence of lipopolysaccharide, and the cytotoxicity was significantly augmented by i.p. injection of N-CWS. On the other hand, the responsiveness of peritoneal macrophages to lipopolysaccharide was found to be poor in A23-bearing mice and the tumoricidal activity was only weakly augmented by N-CWS. These results strongly suggest that M-CSF plays an important role not only in the maturation of macrophage progenitors but also in the induction and the accumulation of activated macrophages.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2645051     DOI: 10.1007/bf00199111

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  29 in total

1.  The effect of a growing tumor and its removal on the cytotoxicity of macrophages from cultured bone marrow cells.

Authors:  B Fisher; N Wolmark; J Coyle; E A Saffer
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

2.  Tumor specificity, serum inhibition, and influence of regional lymph nodes on cytotoxic macrophages from cultured bone marrow.

Authors:  B Fisher; J T Hanlon; J Linta; E Saffer
Journal:  Cancer Res       Date:  1977-10       Impact factor: 12.701

3.  Early hematopoietic events during tumor growth in mice.

Authors:  C L Hardy; L Balducci
Journal:  J Natl Cancer Inst       Date:  1986-03       Impact factor: 13.506

4.  Antibody-dependent cellular cytotoxicity against tumor cells. I. Cultivated bone marrow-derived macrophages kill tumor targets.

Authors:  M L Lohmann-Matthes; W Domzig; H Taskov
Journal:  Eur J Immunol       Date:  1979-04       Impact factor: 5.532

5.  Characteristics of long-term cultures of proliferating, mononuclear phagocytes from bone marrow.

Authors:  J W van der Meer; J S van de Gevel; R van Furth
Journal:  J Reticuloendothel Soc       Date:  1983-09

6.  In vitro tumor cell killing by peritoneal macrophages from mitomycin C-treated rats.

Authors:  T Ogura; H Shindo; O Shinzato; M Namba; T Masuno; T Inoue; S Kishimoto; Y Yamamura
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

7.  Bone marrow derived diffuse colonies: their cytotoxic potential, morphology, and antigenic phenotype.

Authors:  M H Claësson; L Olsson; L Martinsen; P Brix-Poulsen
Journal:  Exp Hematol       Date:  1982-09       Impact factor: 3.084

8.  Mechanism(s) of in vitro macrophage activation with Nocardia rubra cell wall skeleton: the effects on macrophage activating factor production by lymphocytes.

Authors:  T Masuno; S Hayashi; M Ito; T Ikeda; T Ogura; S Kishimoto; Y Yamamura
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

9.  High proliferation of granulocyte-macrophage progenitors in tumor-bearing mice.

Authors:  L Balducci; C Hardy
Journal:  Cancer Res       Date:  1983-10       Impact factor: 12.701

10.  Administration of recombinant interleukin 2 to mice enhances production of hemopoietic and natural killer cells.

Authors:  P F Piguet; G Grau; C Irle; P Vassalli
Journal:  Eur J Immunol       Date:  1986-10       Impact factor: 5.532

View more
  6 in total

1.  Promotion of murine antitumor activity by prothymosin alpha treatment: I. Induction of tumoricidal peritoneal cells producing high levels of tumour necrosis factor alpha.

Authors:  M Papanastasiou; C N Baxevanis; M Papamichail
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

2.  Bindarit: an anti-inflammatory small molecule that modulates the NFκB pathway.

Authors:  Eugenio Mora; Angelo Guglielmotti; Giuseppe Biondi; Paolo Sassone-Corsi
Journal:  Cell Cycle       Date:  2012-01-01       Impact factor: 4.534

3.  5α-reduced glucocorticoids exhibit dissociated anti-inflammatory and metabolic effects.

Authors:  C Yang; M Nixon; C J Kenyon; D E W Livingstone; R Duffin; A G Rossi; B R Walker; R Andrew
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

4.  Production of reactive nitrogen intermediates by bone marrow-derived macrophages on treatment with cisplatin in vitro.

Authors:  A Sodhi; A Suresh
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

5.  PI3KC3 complex subunit NRBF2 is required for apoptotic cell clearance to restrict intestinal inflammation.

Authors:  Ming-Yue Wu; Le Liu; Er-Jin Wang; Hai-Tao Xiao; Cui-Zan Cai; Jing Wang; Huanxing Su; Yitao Wang; Jieqiong Tan; Zhuohua Zhang; Juan Wang; Maojing Yao; De-Fang Ouyang; Zhenyu Yue; Min Li; Ye Chen; Zhao-Xiang Bian; Jia-Hong Lu
Journal:  Autophagy       Date:  2020-03-19       Impact factor: 16.016

6.  Role of Hepatic Deposited Immunoglobulin G in the Pathogenesis of Liver Damage in Systemic Lupus Erythematosus.

Authors:  Xiang Fang; Muhammad Haidar Zaman; Xuanxuan Guo; Huimin Ding; Changhao Xie; Xiaojun Zhang; Guo-Min Deng
Journal:  Front Immunol       Date:  2018-06-25       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.